<SEC-DOCUMENT>0001104659-23-117201-index.html : 20231113 <SEC-HEADER>0001104659-23-117201.hdr.sgml : 20231113 <ACCEPTANCE-DATETIME>20231113160647 ACCESSION NUMBER: 0001104659-23-117201 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 EFFECTIVENESS DATE: 20231113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-275502 FILM NUMBER: 231398669 BUSINESS ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tm2327472d1_s8.htm <DESCRIPTION>FORM S-8 <TEXT> Document 1 - file: tm2327472d1_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2327472d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2327472d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tm2327472d1_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: tm2327472d1_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>4 <FILENAME>tm2327472d1_ex23-2.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 4 - file: tm2327472d1_ex23-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.3 <SEQUENCE>5 <FILENAME>tm2327472d1_ex23-3.htm <DESCRIPTION>EXHIBIT 23.3 <TEXT> Document 5 - file: tm2327472d1_ex23-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>6 <FILENAME>tm2327472d1_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 6 - file: tm2327472d1_ex-filingfees.htm
</DOCUMENT> </SEC-DOCUMENT>